| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.91 | $57.23 (0%) | 🛒 Add to cart |
| 60 | $1.81 | $114.47 $108.44 (5%) | 🛒 Add to cart |
| 90 | $1.77 | $171.70 $159.65 (7%) | 🛒 Add to cart |
| 120 | $1.76 | $228.93 $210.86 (8%) | 🛒 Add to cart |
| 180 | $1.74 | $343.40 $313.28 (9%) | 🛒 Add to cart |
| 270 | $1.73
Best per pill | $515.10 $465.90 (10%) | 🛒 Add to cart |
Similar products
More info:
dutas
Dutasteride, marketed under brand names like Avodart and more recently in generic formulations, represents one of the most potent 5-alpha reductase inhibitors available in clinical practice. As a synthetic 4-azasteroid compound, it works by inhibiting both type 1 and type 2 isoforms of the 5-alpha reductase enzyme, which converts testosterone to the more potent androgen dihydrotestosterone (DHT). This dual inhibition creates a near-total suppression of DHT production, making dutasteride particularly valuable for androgen-dependent conditions where DHT plays a central pathophysiological role.
avodart
Dutasteride, marketed as Avodart, represents one of the more interesting developments in urological pharmacotherapy over the past two decades. As a 5α-reductase inhibitor, it occupies a unique position in managing benign prostatic hyperplasia, though its applications have expanded beyond initial indications. What’s particularly fascinating is how this molecule differs from its predecessor finasteride in both mechanism and clinical effect. The compound exists as a soft gelatin capsule containing 0.5 mg dutasteride, with inactive ingredients including butylated hydroxytoluene, ferric oxide, gelatin, glycerin, monoglycerides, and titanium dioxide.
finast
Finast represents a significant advancement in 5-alpha reductase inhibitor therapy, specifically developed for managing androgen-related conditions in both men and women. Unlike earlier iterations that often caused systemic side effects, this topical formulation delivers targeted inhibition where it’s needed most - directly at the hair follicles and sebaceous glands. The development took nearly seven years, and I remember our research team arguing for months about whether localized application could achieve meaningful tissue concentrations without significant serum absorption.
propecia
Finasteride 1mg tablets, marketed under the brand name Propecia, represent a significant advancement in the pharmacological management of androgenetic alopecia. This 5α-reductase inhibitor specifically targets the hormonal pathway responsible for pattern hair loss in men, offering a scientifically-validated approach that differs fundamentally from topical treatments and cosmetic solutions. The development journey wasn’t straightforward - our team initially struggled with dosage optimization, with some clinicians advocating for higher doses while others worried about systemic effects.
tugain solution
Tugain Solution represents one of the more established topical treatments in the hair restoration space, specifically formulated with minoxidil as its active pharmaceutical ingredient. Over the years, I’ve seen countless patients walk through my clinic doors clutching boxes of this solution, often after exhausting various over-the-counter options with little to show for it. The journey typically begins with that first noticeable thinning at the crown or a receding hairline that no longer responds to cosmetic concealment.
a ret gel
A ret gel represents one of the most significant advances in topical retinoid therapy we’ve seen in years. Unlike traditional tretinoin creams that often cause significant irritation, this stabilized retinaldehyde formulation delivers comparable efficacy with markedly improved tolerability. The development team spent nearly three years perfecting the encapsulation technology that protects the retinaldehyde molecule from oxidation while ensuring controlled release into the epidermis. I remember our lead formulator, Dr. Chen, arguing passionately against adding the penetration enhancers that marketing kept pushing for – turned out she was absolutely right to prioritize stability over immediate absorption.
Abana: Comprehensive Cardiovascular Support Through Herbal Synergy - Evidence-Based Review
Product Description: Abana represents one of those formulations that initially made me skeptical - another herbal blend claiming cardiovascular benefits. But after reviewing the constituent herbs and seeing the clinical data, then observing patient responses over fifteen years, I’ve come to respect its place in integrative cardiology. The formula combines traditional Ayurvedic herbs with modern delivery systems, specifically targeting lipid metabolism and stress-related cardiovascular strain. 1. Introduction: What is Abana? Its Role in Modern Medicine When patients first ask me “what is Abana used for,” I explain it’s not a single herb but a sophisticated polyherbal formulation that bridges traditional Ayurvedic medicine and contemporary cardiovascular care.
abhigra
Let me walk you through what we’ve observed with Abhigra over the past three years. When the development team first brought me the preliminary data, I’ll admit I was skeptical—another “breakthrough” botanical extract claiming to modulate inflammatory pathways. But the pharmacokinetics were different. Dr. Chen from pharmacology kept insisting, “The delivery system changes everything,” while our clinical lead Dr. Patel argued we were over-engineering something that should remain simple. This tension actually improved the final product.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in the atypical antipsychotic class with its unique pharmacodynamic profile. Unlike earlier antipsychotics that primarily functioned as dopamine antagonists, aripiprazole acts as a partial dopamine D2 and serotonin 5-HT1A receptor agonist while simultaneously antagonizing serotonin 5-HT2A receptors. This distinctive mechanism—often described as dopamine system stabilization—provides effective symptom control while minimizing side effects like extrapyramidal symptoms and hyperprolactinemia that plagued first-generation agents.